Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study

Muideen Tunbosun Olaiya, Hung-Yi Chiou, Jiann-Shing Jeng, Li-Ming Lien, Fang-I Hsieh, Muideen Tunbosun Olaiya, Hung-Yi Chiou, Jiann-Shing Jeng, Li-Ming Lien, Fang-I Hsieh

Abstract

Objective: To investigate whether gallstone disease (GD) increases the risk of developing cardiovascular disease (CVD) in a large population-based cohort.

Methods: A study population including 6,981 patients with GD was identified from The Taiwan National Health Insurance Research Database between 2004 and 2005. GD patients were defined as patients with principal discharge diagnoses of cholelithiasis using the ICD-9-CM code 574. 27,924 patients without GD were randomly selected and matched for age and gender. All patients were followed for 6 years or until diagnosis for CVD. Cox proportional hazards regression model was used to assess the risk of developing CVD with adjustment for age, gender and co-morbid conditions.

Results: During the six years follow-up period, 935 patients with GD and 2,758 patients without GD developed CVD. Patients with GD had an elevated risk of CVD (HR, 1.32; 95% CI, 1.22-1.43) when compared with those without GD. Similar relationship was observed when CVD was categorized i.e. stroke (HR, 1.15; 95% CI, 1.01-1.32), coronary heart disease (HR, 1.42; 95% CI, 1.28-1.58) and heart failure (HR, 1.31; 95% CI, 1.00-1.73). When GD was classified according to the level of severity, using patients without GD as reference, the risks of CVD were elevated in patients with non-severe GD (HR, 1.34; 95% CI, 1.24-1.46) as well as those with severe GD (HR, 1.20, 95% CI, 1.02-1.40), after adjusting for age, gender and comorbidities. In age-stratified analysis, patients aged 18-40 years with GD were at higher risk of developing CVD (HR, 1.42; 95% CI, 1.09-1.84) than older GD patients.

Conclusion: This study found an increased risk of CVD in patients diagnosed with GD. The excess risk was particularly high in younger GD patients. Prevention of GD could help reduce the risk of developing CVD, and the better effect could be achieved for the younger age groups.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Kaplan-Meier 6-year CVD event free…
Figure 1. Kaplan-Meier 6-year CVD event free probability curves for gallstone and non-gallstone disease groups.

References

    1. Stinton LM, Shaffer EA (2012) Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer. Gut Liver 6: 172-187. doi:10.5009/gnl.2012.6.2.172. PubMed: .
    1. Shaffer EA (2006) Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20: 981-996. doi:10.1016/j.bpg.2006.05.004. PubMed: .
    1. Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K et al. (2011) The Global Burden of Cardiovascular Disease. J Cardiovasc Nurs 26: S5-S14. doi:10.1097/JCN.0b013e318213efcf. PubMed: .
    1. WHO (2013) Cardiovascular Disease: The Atlas of Heart Disease and Stroke. Geneva: World Health Organization; Available: . Accessed 2012 November 12.
    1. Kozak LJ, Hall MJ, Owings MF (2002) National Hospital Discharge Survey: 2000 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13: 1-194. PubMed: .
    1. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases - PartII: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104: 2855-2864. doi:10.1161/hc4701.099488. PubMed: .
    1. WHO (2012) Cardiovascular diseases. Geneva: World Health Organization; Available: . Accessed 2012 November 12.
    1. Vogt DP (2002) Gallbladder disease: An update on diagnosis and treatment. Cleve Clin J Med 69: 977-984. doi:10.3949/ccjm.69.12.977. PubMed: .
    1. Zaliekas J, Munson JL (2008) Complications of gallstones: the Mirizzi syndrome, gallstone ileus, gallstone pancreatitis, complications of "lost" gallstones. Surg Clin North Am 88: 1345-1368. doi:10.1016/j.suc.2008.07.011. PubMed: .
    1. Browning JD, Horton JD (2003) Gallstone disease and its complications. Semin Gastrointest Dis 14: 165-177. PubMed: .
    1. Méndez-Sánchez N, Bahena-Aponte J, Chávez-Tapia NC, Motola-Kuba D, Sánchez-Lara K et al. (2005) Strong association between gallstones and cardiovascular disease. American. Am J Gastroenterol 100: 827-830. doi:10.1111/j.1572-0241.2005.41214.x. PubMed: .
    1. Ruhl CE, Everhart JE (2011) Gallstone Disease Is Associated With Increased Mortality in the United States. Gastroenterology 140: 508-516. doi:10.1053/j.gastro.2010.10.060. PubMed: .
    1. Chavez-Tapia NC, Kinney-Novelo IM, Sifuentes-Rentería SE, Torres-Zavala M, Castro-Gastelum G et al. (2012) Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease. Ann Hepatol 11: 85-89. PubMed: .
    1. Portincasa P, Moschetta A, Palasciano G (2006) Cholesterol gallstone disease. Lancet 368: 230-239. doi:10.1016/S0140-6736(06)69044-2. PubMed: .
    1. Scott J (2004) Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev 14: 271-279. doi:10.1016/j.gde.2004.04.012. PubMed: .
    1. Eaton CB (2005) Traditional and emerging risk factors for cardiovascular disease. Prim Care 32: 963-976. doi:10.1016/j.pop.2005.09.009. PubMed: .
    1. Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A et al. (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113: 791-798. doi:10.1161/CIRCULATIONAHA.105.548206. PubMed: .
    1. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P (1999) Sex, age, cardiovascular risk factors, and coronary heart disease - A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 99: 1165-1172. doi:10.1161/01.CIR.99.9.1165. PubMed: .
    1. Nieto FJ (1999) Cardiovascular disease and risk factor epidemiology: A look back at the epidemic of the 20th century. Am J Public Health 89: 292-294. doi:10.2105/AJPH.89.3.292. PubMed: .
    1. Méndez-Sánchez N, Zamora-Valdés D, Flores-Rangel JA, Pérez-Sosa JA, Vásquez-Fernández F et al. (2008) Gallstones are associated with carotid atherosclerosis. Liver Int 28: 402-406. PubMed: .
    1. Ata N, Kucukazman M, Yavuz B, Bulus H, Dal K et al. (2011) The metabolic syndrome isassociated with complicated gallstone disease. Can J Gastroenterol 25: 274-276. PubMed: .
    1. National Health Insurance Research Database Taiwan. Available: . Accessed 2012 November 14.
    1. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20: 236-242. doi:10.1002/pds.2087. PubMed: .
    1. Huang J, Chang CH, Wang JL, Kuo HK, Lin JW et al. (2009) Nationwide epidemiological study of severe gallstone disease in Taiwan. BMC Gastroenterol 9: 63. doi:10.1186/1471-230X-9-63. PubMed: .
    1. Cho JY, Han HS, Yoon YS, Ahn KS (2010) Risk factors for acute cholecystitis and a complicated clinical course in patients with symptomatic cholelithiasis. Arch Surg 145: 329-333. doi:10.1001/archsurg.2010.35. PubMed: .
    1. Bortnichak EA, Freeman DH Jr., Ostfeld AM, Castelli WP, Kannel WB et al. (1985) The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am J Epidemiol 121: 19-30. PubMed: .
    1. Marschall HU, Einarsson C (2007) Gallstone disease. J Intern Med 261: 529-542. doi:10.1111/j.1365-2796.2007.01783.x. PubMed: .
    1. Chilton RJ (2004) Pathophysiology of coronary heart disease: a brief review. J Am Osteopath Assoc 104: S5-S8. PubMed: .
    1. Twickler MT, Cramer MJ, van Erpecum KJ (2005) Insulin-like growth factor-1: a common metabolic pathway in the origin of both gallstones and coronary heart disease. Am J Gastroenterol 100: 2363-2364. doi:10.1111/j.1572-0241.2005.50650_3.x. PubMed: .
    1. Moschetta A, Twickler TB, Rehfeld JF, van Ooteghem NA, Cabezas MC et al. (2004) Effects of growth hormone deficiency and recombinant growth hormone therapy on postprandial gallbladder motility and cholecystokinin release. Dig Dis Sci 49: 529-534. doi:10.1023/B:DDAS.0000020515.75879.2f. PubMed: .
    1. Stolk MF, van Erpecum KJ, Renooij W, Portincasa P, van de Heijning BJ et al. (1995) Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones. Gastroenterology 108: 1882-1888. doi:10.1016/0016-5085(95)90153-1. PubMed: .
    1. Ren J, Samson WK, Sowers JR (1999) Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31: 2049-2061. doi:10.1006/jmcc.1999.1036. PubMed: .
    1. Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J et al. (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27: 2684-2690. doi:10.1161/ATVBAHA.107.156257. PubMed: .
    1. Conti E, Musumeci MB, De Giusti M, Dito E, Mastromarino V et al. (2011) IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci (Lond) 120: 377-402. doi:10.1042/CS20100400. PubMed: .
    1. Geetha A (2002) Evidence for oxidative stress in the gall bladder mucosa of gall stone patients. J Biochem Mol Biol Biophys 6: 427-432. doi:10.1080/1025814021000036179. PubMed: .
    1. Otani H (2011) Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15: 1911-1926. doi:10.1089/ars.2010.3739. PubMed: .
    1. Sakuta H, Suzuki T (2005) Plasma total homocysteine and gallstone in middle-aged Japanese men. J Gastroenterol 40: 1061-1064. doi:10.1007/s00535-005-1691-z. PubMed: .
    1. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L et al. (2001) Oxidative stress and homocysteine in coronary artery disease. Clin Chem 47: 887-892. PubMed: .
    1. Schroecksnadel K, Grammer TB, Boehm BO, März W, Fuchs D (2010) Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost 103: 926-935. doi:10.1160/TH09-07-0422. PubMed: .
    1. Sin DD, Man SF (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 83: 8-13. doi:10.1139/y04-116. PubMed: .
    1. Lamon-Fava S, Wilson PW, Schaefer EJ (1996) Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 16: 1509-1515. doi:10.1161/01.ATV.16.12.1509. PubMed: .

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren